20 results
8-K
EX-10.1
ARCT
Arcturus Therapeutics Holdings Inc
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
available by the Company for examination and packaging by the Agent in New York City not later than 12:00 P.M., New York City time, on the Business Day prior … Subsidiaries and the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, advertising, labeling
10-K
ixmnarkgjzonz12p
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
c9rpolt8 r9c
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
3l489da89 85zd
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
g30mo50o
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-1.1
3qjr4
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-1.1
wy4 9q5ygobfmeg
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
q7tt0 98vn4
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
S-4
1qjj s9gk
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
S-4/A
7o1xkaj 4u
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
424B3
xj8w f0u5x77
12 Apr 19
Prospectus supplement
4:39pm
- Prev
- 1
- Next